ライフサイエンスコーパス: esophageal squamous cell carcinoma

1 his effect was not observed in patients with esophageal squamous cell carcinoma.

2 cocutaneous candidiasis, hypothyroidism, and esophageal squamous cell carcinoma.

3 solid and hematologic malignancies including esophageal squamous cell carcinoma.

4 involved in many types of cancer, including esophageal squamous cell carcinoma.

5 R and IGFBP-3 was observed in 60% of primary esophageal squamous cell carcinomas.

6 ma-associated gene-A1 (MAGE-A1) and New York-esophageal squamous cell carcinoma-1 (NY-ESO-1) proteins

7 ients: 36 with Barrett's metaplasia, 23 with esophageal squamous cell carcinoma, 10 with esophageal a

8 of esophageal adenocarcinomas, 323 cases of esophageal squamous cell carcinoma, 698 cases of gastric

9 denocarcinoma, esophageal adenocarcinoma, or esophageal squamous cell carcinoma.Among older American

10 ion of LTB4R, LTB4R2, CYSLTR1 and CYSLTR2 in esophageal squamous cell carcinoma and adjacent non-tran

11 In conclusion, direct co-culture of esophageal squamous cell carcinoma and fibroblasts induc

12 e have applied this methodology to a case of esophageal squamous cell carcinoma and identified severa

13 P-3 mRNA was overexpressed in 80% of primary esophageal squamous cell carcinomas and 60% of primary e

14 ferent types of engineered tumors with human esophageal squamous cell carcinomas and adenocarcinomas.

15 pithelium, but its expression is absent from esophageal squamous cell carcinomas and adenocarcinomas.

16 ng, we analyzed tissue microarrays of paired esophageal squamous cell carcinomas and adjacent normal

17 In total, 170 gastric adenocarcinomas, 68 esophageal squamous cell carcinomas, and 270 head and ne

18 ese data indicate that molecular profiles in esophageal squamous cell carcinoma are highly consistent

19 ACKR3 expression in human breast, lung, and esophageal squamous cell carcinoma cancer xenografts.

20 In addition to esophageal squamous cell carcinoma, cancers of the small

21 characterize the interaction of KYSE-410, an esophageal squamous cell carcinoma cell line, and fibrob

22 d fragile histidine triad (FHIT) genes in 22 esophageal squamous cell carcinoma cell lines and 47 pri

23 ngineered human esophageal keratinocytes and esophageal squamous cell carcinoma cells to delineate th

24 possible beneficial effect for any candidate esophageal squamous cell carcinoma chemopreventive agent

25 test on >20 000 genes/regions in a study of esophageal squamous cell carcinoma (ESCC) and detected a

26 istic curve profiles, clearly distinguishing esophageal squamous cell carcinoma (ESCC) and EAC from n

27 EpCAM overexpression was 98% in both esophageal squamous cell carcinoma (ESCC) and esophageal

28 4 rs13042395 polymorphism modify the risk of esophageal squamous cell carcinoma (ESCC) and gastric ca

29 denocarcinoma have increased, while rates of esophageal squamous cell carcinoma (ESCC) and gastric no

30 mechanisms underlying the poor prognosis of esophageal squamous cell carcinoma (ESCC) are not well u

31 A rapid progression of esophageal squamous cell carcinoma (ESCC) causes a high

32 novel methylated genes that we identified in esophageal squamous cell carcinoma (ESCC) cell lines, N-

33 egulates cell proliferation and apoptosis in esophageal squamous cell carcinoma (ESCC) cells.

34 Imaging strategies that detect early stage esophageal squamous cell carcinoma (ESCC) could improve

35 However, its role in esophageal squamous cell carcinoma (ESCC) has not been s

36 Previous studies of esophageal squamous cell carcinoma (ESCC) have shown a h

37 wide association study of gastric cancer and esophageal squamous cell carcinoma (ESCC) in ethnic Chin

38 tial genome-wide association study (GWAS) on esophageal squamous cell carcinoma (ESCC) in Han Chinese

39 ee genome-wide association studies (GWAS) of esophageal squamous cell carcinoma (ESCC) in individuals

40 beta-catenin/TCF-dependent transcription in esophageal squamous cell carcinoma (ESCC) independent of

41 Esophageal squamous cell carcinoma (ESCC) is among the m

42 Esophageal squamous cell carcinoma (ESCC) is an aggressi

43 Esophageal squamous cell carcinoma (ESCC) is known to be

44 Esophageal squamous cell carcinoma (ESCC) is prevalent w

45 Esophageal squamous cell carcinoma (ESCC) is the commone

46 The etiology and pathogenesis of esophageal squamous cell carcinoma (ESCC) is thought to

47 Data of 1095 esophageal squamous cell carcinoma (ESCC) patients, incl

48 study, we analyzed PGP9.5 methylation in 50 esophageal squamous cell carcinoma (ESCC) primary tumors

49 ipheral blood lymphocytes from patients with esophageal squamous cell carcinoma (ESCC) receiving chem

50 s (500 to 1500 mum in diameter) from ex vivo esophageal squamous cell carcinoma (ESCC) specimens and

51 11,555 SNPs in a pilot case-control study of esophageal squamous cell carcinoma (ESCC) that included

52 etween changes in gastric mucosa and risk of esophageal squamous cell carcinoma (ESCC) which suggeste

53 in tumor tissues removed from patients with esophageal squamous cell carcinoma (ESCC) with poor prog

54 The cohort was followed for 16.3 y, and 110 esophageal squamous cell carcinoma (ESCC), 151 esophagea

55 role in esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC), although evid

56 ociated with enhanced malignant potential in esophageal squamous cell carcinoma (ESCC), among the dea

57 re esophageal adenocarcinoma (EAC), 176 were esophageal squamous cell carcinoma (ESCC), and 23 were o

58 One subtype, esophageal squamous cell carcinoma (ESCC), is an aggress

59 Esophageal squamous cell carcinoma (ESCC), the major his

60 To characterize genomic instability in esophageal squamous cell carcinoma (ESCC), we examined l

61 One example is esophageal squamous cell carcinoma (ESCC), which is asso

62 susceptible to chronic fungal infection and esophageal squamous cell carcinoma (ESCC).

63 r RNA (mRNA) profiling in predicting pCR for esophageal squamous cell carcinoma (ESCC).

64 ed the role of DNAJB6 in the pathogenesis of esophageal squamous cell carcinoma (ESCC).

65 s of dietary intake of minerals with risk of esophageal squamous cell carcinoma (ESCC).

66 evaluated the probe in preclinical models of esophageal squamous cell carcinoma (ESCC).

67 dies have identified susceptibility loci for esophageal squamous cell carcinoma (ESCC).

68 involved in chemoresistance in patients with esophageal squamous cell carcinoma (ESCC).

69 hern South America, may increase the risk of esophageal squamous cell carcinoma (ESCC).

70 mmation is implicated in the pathogenesis of esophageal squamous cell carcinoma (ESCC).

71 nificance and biological effects of PTTG1 in esophageal squamous cell carcinoma (ESCC).

72 kb interval on human chromosome 13q12.11 for esophageal squamous cell carcinoma (ESCC).

73 d that chromosomal instability was common in esophageal squamous cell carcinoma (ESCC); however, the

74 In a large case-control study of 1126 esophageal squamous cell carcinomas (ESCC) patients and

75 nd STAT3-Tyr705 phosphorylation (P-STAT3) in esophageal squamous cell carcinomas (ESCC, n=49) and Bar

76 ncer (esophageal adenocarcinoma [EAC] and/or esophageal squamous cell carcinoma [ESCC]).

77 rypsinogen expression at the RNA level in 49 esophageal squamous cell carcinomas (ESCCs) and 72 gastr

78 Ps in 127 genes in the EGFR pathway for 1942 esophageal squamous cell carcinomas (ESCCs), 1758 gastri

79 enocarcinomas (EACs) and EGFR overexpressing esophageal squamous cell carcinomas (ESCCs).

80 ficient esophagus, as well as in lingual and esophageal squamous cell carcinoma from carcinogen-treat

81 eal adenocarcinoma h(2)g = 0.24 (0.14-0.34); esophageal squamous cell carcinoma h(2)g = 0.19 (0.07-0.

82 The majority of esophageal squamous cell carcinomas have identifiable p5

83 Esophageal squamous cell carcinoma is a common fatal can

84 Esophageal squamous cell carcinoma is a major histologic

85 We observed similar effects of EGCG in esophageal squamous cell carcinoma KYSE 150 cells and ep

86 effects on gastric adenocarcinoma (AGS) and esophageal squamous cell carcinoma (KYSE30) cancer cells

87 126) and noncardia adenocarcinoma (n = 188), esophageal squamous cell carcinoma (n = 53), and adenoca

88 er human lung adenocarcinomas (n = 39) or in esophageal squamous cell carcinomas (n = 24).

89 nd cysteinylglycine were not associated with esophageal squamous cell carcinoma or head and neck squa

90 d, there is no information about its role in esophageal squamous cell carcinoma (OSCC).

91 Tumor and matched normal tissue from 19 esophageal squamous cell carcinoma patients from a high-

92 O) in a mouse model of human oral-cavity and esophageal squamous-cell carcinoma previously generated

93 Esophageal squamous cell carcinoma remains a leading cau

94 sia, the accepted histological precursor for esophageal squamous cell carcinoma, represents a potenti

95 real data from the 1000 Genomes Project and esophageal squamous cell carcinoma samples show that see

96 nd then stably transfected RRIG1 into a TE-8 esophageal squamous cell carcinoma (SCC) cell line.

97 ound to be a tumor suppressor in gliomas and esophageal squamous cell carcinomas, the mechanisms by w

98 ory effects of zinc on cell proliferation in esophageal squamous cell carcinoma through Orai1.

99 laboratory has used a rodent model of human esophageal squamous cell carcinoma to identify putative

100 In mice bearing esophageal squamous cell carcinoma tumors, to estimate u

101 sis in the rat esophagus is a model of human esophageal squamous cell carcinoma used for investigatio

102 gnosis of esophageal adenocarcinoma, but not esophageal squamous cell carcinoma, was associated with

103 luate the potential role of the WWOX gene in esophageal squamous cell carcinomas, we examined 36 tumo

104 ore frequent in non-Hispanic whites, whereas esophageal squamous cell carcinoma with risk factors of